HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 60.30
-0.10 (-0.17%)
Mar 24, 2026, 1:55 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.76 billion as of March 24, 2026. Its market cap has decreased by -20.13% in one year.
Market Cap
2.76B
Enterprise Value
2.30B
Revenue
290.83M
Ranking
n/a
PE Ratio
24.54
Stock Price
60.30
Market Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.76B, a decrease of -33.74%. That is a compound annual growth rate of -14.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 2.78B | -4.13% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shine-On BioMedical | 3.30B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| BRIM Biotechnology | 3.19B |
| Intech Biopharm | 3.12B |
| Syngen Biotech | 2.98B |
| Apex Biotechnology | 2.91B |
| Sunhawk Vision Biotech | 2.87B |
| GlycoNex Incorporation | 2.55B |